November 2000
ISMP Canada recently has received reports expressing concerns about the labelling on both the small bottle (containing ciprofloxacin microcapsules) and the large bottle (containing the special milky diluent). The diluent bottle prominently states "Cipro Oral Suspension" while the term "diluent" is hardly visible. The problem could result in pharmacists dispensing the diluent accidentally instead of the final reconstituted Cipro suspension.The other concern raised is the microscopic fine-print of the information on the small bottle. The dose of "10 g" is hardly visible. A similar problem existed in the US about a year ago. The November 17, 1999 issue of ISMP Medication Safety Alert! described this safety issue and offered recommendations for action. Bayer Inc. did take the initiative to make a significant change on the labels on the US product. ISMP Canada has contacted Bayer Canada and requested a similar change of labels. Bayer is investigating the situation and considering our recommendations. Stay tuned for more information soon.
